Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.004 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Treatment and Prevention of Enteric Infections With Toxin-binding ProbioticsPaton, A.; Morona, R.; Paton, J.
2003Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulenceMorona, R.; Daniels, C.; Van Den Bosch, L.
2000A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humansPaton, A.; Morona, R.; Paton, J.
2018Role of Streptococcus pneumoniae OM001 operon in capsular polysaccharide production, virulence and survival in human salivaAhmad, Z.; Harvey, R.; Paton, J.; Standish, A.; Morona, R.; Ho, P.L.
1997Characterization of the Capsular Polysaccharide Biosynthesis Locus of Streptococcus pneumoniae Type 19FPaton, J.; Morona, J.; Morona, R.
2012Escherichia coli 83972 expressing a P fimbriae oligosaccharide receptor mimic impairs adhesion of uropathogenic E. coliWatts, R.; Tan, C.; Ulett, G.; Carey, A.; Totsika, M.; Idris, A.; Paton, A.; Morona, R.; Paton, J.; Schembri, M.
2004Refinement of a therapeutic Shiga toxin-binding probiotic for human trialsPinyon, R.; Paton, J.; Paton, A.; Botten, J.; Morona, R.
2012Bioengineered microbes in disease therapyPaton, A.; Morona, R.; Paton, J.
2014IcsA is a Shigella flexneri adhesin regulated by the type III secretion system and required for pathogenesisZumsteg, A.; Goosmann, C.; Brinkmann, V.; Morona, R.; Zychlinsky, A.
2013Impact of dynasore an inhibitor of dynamin II on Shigella flexneri infectionLum, M.; Attridge, S.; Morona, R.; Mantis, N.J.